Sterling Capital Management LLC Sells 11,630 Shares of GE HealthCare Technologies Inc. $GEHC

Sterling Capital Management LLC trimmed its holdings in GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 42.8% in the first quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 15,539 shares of the company’s stock after selling 11,630 shares during the period. Sterling Capital Management LLC’s holdings in GE HealthCare Technologies were worth $1,106,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. Western Wealth Management LLC increased its holdings in shares of GE HealthCare Technologies by 2.4% during the 4th quarter. Western Wealth Management LLC now owns 5,240 shares of the company’s stock worth $430,000 after acquiring an additional 125 shares during the last quarter. United Community Bank lifted its holdings in GE HealthCare Technologies by 10.2% during the 4th quarter. United Community Bank now owns 1,410 shares of the company’s stock valued at $116,000 after purchasing an additional 130 shares during the last quarter. Parkside Financial Bank & Trust boosted its position in GE HealthCare Technologies by 3.9% during the fourth quarter. Parkside Financial Bank & Trust now owns 3,567 shares of the company’s stock worth $293,000 after purchasing an additional 134 shares during the period. Thoma Capital Management LLC boosted its position in GE HealthCare Technologies by 1.4% during the fourth quarter. Thoma Capital Management LLC now owns 9,918 shares of the company’s stock worth $814,000 after purchasing an additional 136 shares during the period. Finally, Quadrant Capital Group LLC increased its holdings in shares of GE HealthCare Technologies by 1.1% in the fourth quarter. Quadrant Capital Group LLC now owns 12,557 shares of the company’s stock valued at $1,030,000 after purchasing an additional 140 shares during the last quarter. 82.06% of the stock is currently owned by institutional investors.

GE HealthCare Technologies Price Performance

NASDAQ:GEHC opened at $64.01 on Wednesday. GE HealthCare Technologies Inc. has a 52 week low of $58.75 and a 52 week high of $89.77. The company has a debt-to-equity ratio of 0.95, a quick ratio of 0.95 and a current ratio of 1.22. The firm’s 50-day simple moving average is $64.14 and its 200 day simple moving average is $73.62. The firm has a market cap of $29.12 billion, a price-to-earnings ratio of 15.31, a P/E/G ratio of 1.77 and a beta of 0.74.

GE HealthCare Technologies (NASDAQ:GEHC) last posted its quarterly earnings data on Wednesday, April 29th. The company reported $0.99 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $1.07 by ($0.08). GE HealthCare Technologies had a net margin of 9.10% and a return on equity of 20.46%. The business had revenue of $5.13 billion during the quarter, compared to the consensus estimate of $5.04 billion. During the same period in the prior year, the firm earned $1.01 EPS. The business’s revenue for the quarter was up 7.4% on a year-over-year basis. GE HealthCare Technologies has set its FY 2026 guidance at 4.800-5.000 EPS. As a group, sell-side analysts predict that GE HealthCare Technologies Inc. will post 4.89 earnings per share for the current year.

Insider Buying and Selling

In related news, Director Rodney F. Hochman acquired 1,618 shares of the stock in a transaction on Tuesday, May 12th. The shares were purchased at an average price of $62.03 per share, for a total transaction of $100,364.54. Following the purchase, the director directly owned 1,618 shares in the company, valued at approximately $100,364.54. The trade was a ∞ increase in their ownership of the stock. The purchase was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, CEO Peter J. Arduini acquired 4,169 shares of the stock in a transaction on Thursday, April 30th. The shares were bought at an average price of $59.92 per share, for a total transaction of $249,806.48. Following the purchase, the chief executive officer owned 259,424 shares in the company, valued at approximately $15,544,686.08. This trade represents a 1.63% increase in their ownership of the stock. The disclosure for this purchase is available in the SEC filing. Insiders acquired 21,847 shares of company stock valued at $1,361,355 in the last quarter. Corporate insiders own 0.36% of the company’s stock.

Analysts Set New Price Targets

GEHC has been the topic of several research analyst reports. Royal Bank Of Canada initiated coverage on shares of GE HealthCare Technologies in a research report on Tuesday, June 23rd. They issued an “outperform” rating and a $80.00 price objective on the stock. BTIG Research decreased their price target on shares of GE HealthCare Technologies from $85.00 to $80.00 and set a “buy” rating on the stock in a research note on Wednesday, April 29th. The Goldman Sachs Group reiterated a “neutral” rating on shares of GE HealthCare Technologies in a research note on Monday, June 8th. JPMorgan Chase & Co. lowered their price target on shares of GE HealthCare Technologies from $80.00 to $65.00 and set a “neutral” rating on the stock in a report on Thursday, April 30th. Finally, Jefferies Financial Group cut their price objective on shares of GE HealthCare Technologies from $105.00 to $90.00 in a research report on Thursday, April 30th. Ten analysts have rated the stock with a Buy rating and nine have assigned a Hold rating to the stock. Based on data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average price target of $80.20.

GE HealthCare Technologies Company Profile

GE HealthCare Technologies (NASDAQ: GEHC) is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.

In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.